Cassier, P. A., & Hohenberger, P. (2012). Outcome of patients with platelet-derived growth factor receptor alpha-mutated gastrointestinal stromal tumors in the tyrosine kinase inhibitor era. Clinical cancer research, 18(16), . https://doi.org/10.1158/1078-0432.CCR-11-3025
Chicago Style (17th ed.) CitationCassier, Philippe A., and Peter Hohenberger. "Outcome of Patients with Platelet-derived Growth Factor Receptor Alpha-mutated Gastrointestinal Stromal Tumors in the Tyrosine Kinase Inhibitor Era." Clinical Cancer Research 18, no. 16 (2012). https://doi.org/10.1158/1078-0432.CCR-11-3025.
MLA (9th ed.) CitationCassier, Philippe A., and Peter Hohenberger. "Outcome of Patients with Platelet-derived Growth Factor Receptor Alpha-mutated Gastrointestinal Stromal Tumors in the Tyrosine Kinase Inhibitor Era." Clinical Cancer Research, vol. 18, no. 16, 2012, https://doi.org/10.1158/1078-0432.CCR-11-3025.